Cargando…

Dual-targeting of aberrant glucose metabolism in glioblastoma

BACKGROUND: Glioblastoma (GBM) is the most common and malignant primary brain tumor. In contrast to some other tumor types, aberrant glucose metabolism is an important component of GBM growth and chemoresistance. Recent studies of human orthotopic GBM in mice and in situ demonstrated GBM cells rely...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Han, Decollogne, Stephanie, Dilda, Pierre J, Hau, Eric, Chung, Sylvia A, Luk, Peter P, Hogg, Philip J, McDonald, Kerrie L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324653/ https://www.ncbi.nlm.nih.gov/pubmed/25652202 http://dx.doi.org/10.1186/s13046-015-0130-0

Ejemplares similares

The evolving roles and controversies of radiotherapy in the treatment of glioblastoma
por: Hau, Eric, et al.
Publicado: (2016)

Combination of palbociclib and radiotherapy for glioblastoma
por: Whittaker, Shane, et al.
Publicado: (2017)

The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocase
por: Park, Danielle, et al.
Publicado: (2012)

Targeting of two aspects of metabolism in breast cancer treatment
por: Gang, Bevan P, et al.
Publicado: (2014)

Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma
por: Tsoli, Maria, et al.
Publicado: (2018)

Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?
por: McDonald, Kerrie L., et al.
Publicado: (2013)

CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?
por: Schröder, Lisette B. W., et al.
Publicado: (2015)

The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas
por: Wang, Xiaochun, et al.
Publicado: (2020)

The role of TP53 gain-of-function mutation in multifocal glioblastoma
por: Olafson, Lauren R., et al.
Publicado: (2020)

Aberrations of Genomic Imprinting in Glioblastoma Formation
por: Lozano-Ureña, Anna, et al.
Publicado: (2021)

Cytotoxic lanthanum oxide nanoparticles sensitize glioblastoma cells to radiation therapy and temozolomide: an in vitro rationale for translational studies
por: Lu, Victor M., et al.
Publicado: (2020)

DIPG-02. A NOVEL STRATEGY TO RADIOSENSITISE DIFFUSE MIDLINE GLIOMAS VIA DUAL-TARGETING OF GLUCOSE METABOLISM
por: Shen, Han, et al.
Publicado: (2023)

Azathioprine antagonizes aberrantly elevated lipid metabolism and induces apoptosis in glioblastoma
por: Nam, Hye Jin, et al.
Publicado: (2021)

Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)
por: Ha, Wendy, et al.
Publicado: (2019)

A case study of a long-term glioblastoma survivor with unmethylated MGMT and hypermutated genotype
por: Jue, Toni Rose, et al.
Publicado: (2019)

An integrative characterization of recurrent molecular aberrations in glioblastoma genomes
por: Sintupisut, Nardnisa, et al.
Publicado: (2013)

Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas
por: Cook, Kristina M., et al.
Publicado: (2021)

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
por: Jue, Toni Rose, et al.
Publicado: (2017)

Glutathione S-conjugates as prodrugs to target drug-resistant tumors
por: Ramsay, Emma E., et al.
Publicado: (2014)

Network modeling of the transcriptional effects of copy number aberrations in glioblastoma
por: Jörnsten, Rebecka, et al.
Publicado: (2011)

Dual IRE1 RNase functions dictate glioblastoma development
por: Lhomond, Stéphanie, et al.
Publicado: (2018)

IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma
por: Kofuji, Satoshi, et al.
Publicado: (2019)

Impairments in Oxidative Glucose Metabolism in Epilepsy and Metabolic Treatments Thereof
por: McDonald, Tanya, et al.
Publicado: (2018)

The regulatory pattern of target gene expression by aberrant enhancer methylation in glioblastoma
por: Zhao, Xiaoxiao, et al.
Publicado: (2021)

Dual mode of action of metformin on mitochondrial metabolism
por: Andrzejewski, Sylvia, et al.
Publicado: (2014)

Beyond glucose: alternative sources of energy in glioblastoma
por: Caniglia, John L., et al.
Publicado: (2021)

Difficulty suppressing visual distraction while dual tasking
por: McDonald, John J., et al.
Publicado: (2022)

Brain tumors and driving
por: McDonald, Kerrie Leanne
Publicado: (2010)

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
por: Lu, Can, et al.
Publicado: (2022)

Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays
por: Cheung, Hannah C, et al.
Publicado: (2008)

Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
por: Burton, Chase, et al.
Publicado: (2018)

Genetic aberrations in glioblastoma multiforme: translocation of chromosome 10 in an O-2A-like cell line
por: Mao, X, et al.
Publicado: (1999)

Glucose concentration does not affect degradation of a protein that aberrantly engages the endoplasmic reticulum translocon
por: Broshar, Courtney L, et al.
Publicado: (2020)

Glucose concentration does not affect degradation of a protein that aberrantly engages the endoplasmic reticulum translocon
por: Broshar, Courtney L, et al.
Publicado: (2020)

Identification of aberrantly methylated differentially expressed genes in glioblastoma multiforme and their association with patient survival
por: Zhang, Miao, et al.
Publicado: (2019)

3-O-Acetyl-11-keto-β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma
por: Li, Wan, et al.
Publicado: (2020)

Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes
por: Duncan, Christopher G., et al.
Publicado: (2010)

Developing new drugs that activate the protective arm of the renin–angiotensin system as a potential treatment for respiratory failure in COVID-19 patients
por: Latil, Mathilde, et al.
Publicado: (2021)

Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors
por: Camelo, Serge, et al.
Publicado: (2020)

Tumor Cell Invasion in Glioblastoma
por: Vollmann-Zwerenz, Arabel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_06uqho6rc9vf5emk7s5h0qvl2o